Please login to the form below

Not currently logged in
Email:
Password:

The Sudler London Award for Excellence in Mature Brand Revitalisation

Sponsored by

Finalist

AmBisome – Winning the Battle for Hearts and Minds

Gilead in association with Langland


Summary of work

Effective clinical decision-making is vital when managing invasive fungal infections. The immuno-compromised, including cancer and intensive care patients, can succumb to infection and rapidly deteriorate. Delaying or choosing an inappropriate treatment option can be fatal. 

Launched in 1990, Gilead’s AmBisome (liposomal amphotericin B) became the gold standard within the anti-fungal category. However during the following 20 years, the landscape changed. Competitor brands aligned themselves to the two major pathogen classes, effectively bisecting the market and niching AmBisome.

With AmBisome’s market share declining year-on-year, the brief to the 2010 global brand team was simple – keep it ticking over. 

Instead, with cross-functional team-work and customer engagement, AmBisome was cleverly repositioned. Despite being in a functional-led category, the brand was aligned to a key emotional driver, realised through powerful creative work. Enabling the brand to challenge customers’ mindsets. Coupled with a strong clinical rationale, the campaign targeted diversified key segments and delivered consistently through innovative tactics. 

Effective affiliate management led to excellent local implementation. Following years of declining performance, AmBisome, two decades post-launch, demonstrated market share growth. Internal attitudes were transformed and the campaign became a catalyst for a new chapter in its life cycle. 

 

 

Executive summary as submitted


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMR

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics